Eighteen-year-old Jesse Gelsinger died at the University of Pennsylvania last September 17,
four days after receiving a relatively high dose of an experimental gene therapy, a
Already a Digital subscriber? Sign-in Now
If your institution has site license access, enter here.



See what we're tweeting about






Comments
Add Comment